It's good to hear that Oracle Corporation (ORCL) is capturing the public glare once again, after an incredible reversal in its price action, and what better way to do it than through solid execution?

Ader reiterated an Overweight rating on Oracle shares with a price target of $300. Some analysts adjusted their outlooks ...

Oracle Health launches clinical AI note tool to reduce documentation time and streamline workflows in inpatient and emergency department settings.

Oracle's backlog was the centerpiece of the results. CEO Safra Catz revealed that the company's remaining performance obligation (RPO) -- a backlog of future sales -- rose to $553 billion, surging 325 ...

Oracle CEO Clayton Magouyrk said on an earnings call the company's model of having customers provide data chips for new data center builds is working.

The bearish perspective that Oracle is a legacy company losing the cloud battle is directly countered by the 84% increase in ...

Oracle (ORCL) earnings show 20% revenue growth with stable margins, strong cloud/AI backlog and upside valuation potential.

Oracle's overall revenue increased 22% year over year in the fiscal third quarter, which ended on Feb. 28, according to a statement. Net income rose to $3.72 billion, or $1.27 a share, from $2.94 ...

Oracle shares surged about 12% on Wednesday after the software giant's upbeat revenue forecast eased concerns over its hefty ...

Oracle's cloud infrastructure business is accelerating rapidly, but investors should weigh the company's massive capital expenditure plans before buying shares.

Live Updates Conference Call Highlights 18 hours ago Here’s the key highlights from Oracle’s conference call: First 20/20 ...